Absorbable Surgical Sutures Market Size & Share 2026 – 2034

Absorbable Surgical Sutures Market Size

The global absorbable surgical sutures market was estimated at USD 3.15 billion in 2025. The market is expected to grow from USD 3.3 billion in 2026 to USD 5.2 billion in 2034, growing at a CAGR of 5.1%. The global market is expanding steadily, driven by the rising prevalence of chronic diseases, an increase in surgical procedures worldwide, advancements in suture materials, and a growing number of gynecological surgeries.

The absorbable surgical sutures market continues to expand alongside the broader surgical sutures market, supported by increasing surgical volumes, advancements in surgical devices and sutures, and growing preference for dissolvable wound closure products. Absorbable sutures, also referred to as dissolvable sutures, are widely adopted across general, orthopedic, cardiovascular, dental, and gynecological procedures due to their ability to naturally degrade within the body and reduce follow-up suture removal requirements.
 

The absorbable surgical sutures market size is growing steadily across major healthcare economies, including the U.S., Germany, the UK, France, Italy, Spain, China, Japan, South Korea, and India, while the GCC and South America surgical sutures markets are also witnessing increased demand driven by expanding healthcare infrastructure and rising access to surgical care.
 

Market growth is further supported by the increasing use of multifilament and braided absorbable sutures, particularly in procedures requiring enhanced knot security and tissue support. In addition, the growing adoption of advanced surgical devices and sutures is contributing to innovation across the surgical suture market. As healthcare providers focus on improving patient outcomes and procedural efficiency, absorbable surgical sutures market share is expected to strengthen within the global surgical sutures market, creating opportunities across hospital, specialty clinic, and ambulatory surgical center settings.
 

Market Dynamics

Drivers

Increasing prevalence of chronic diseases

The rising prevalence of chronic diseases, including cardiovascular disorders, diabetes, cancer, and obesity, is driving growth in the absorbable surgical sutures market. Increasing surgical procedure volumes across multiple specialties are boosting demand for advanced wound closure solutions. Absorbable sutures support faster recovery, reduce patient discomfort, and align with minimally invasive surgical trends.

Rising surgical procedures worldwide

The rising number of surgical procedures worldwide is a key factor driving growth in the absorbable surgical sutures market. Increasing demand for orthopedic, cardiovascular, gynecological, ophthalmic, and general surgeries, supported by aging populations and a growing burden of chronic diseases, is fueling the need for effective wound closure products. Absorbable sutures are widely preferred because they eliminate the need for removal, reduce post-operative complications, and improve patient comfort. The expanding adoption of minimally invasive procedures and advancements in surgical techniques are further accelerating demand for absorbable sutures across hospitals, specialty clinics, and ambulatory surgical centers.

Opportunity

Growing demand for minimally invasive surgeries

The growing demand for minimally invasive surgeries is accelerating the adoption of absorbable surgical sutures worldwide. Procedures performed through smaller incisions require advanced wound closure solutions that promote faster healing, reduce scarring, and minimize the risk of post-operative complications. Absorbable sutures are increasingly preferred in laparoscopic, robotic-assisted, and other minimally invasive procedures because they eliminate the need for suture removal and enhance patient comfort. As healthcare providers focus on shorter hospital stays, quicker recovery times, and improved surgical outcomes, the use of absorbable sutures continues to expand across a wide range of surgical specialties.

Restraint/Challenge

High cost of procedures

The high cost of surgical procedures remains a key challenge for the absorbable surgical sutures market. Advanced surgeries often involve significant expenses related to hospitalization, surgical equipment, specialized healthcare professionals, and post-operative care. Although absorbable sutures offer long-term clinical benefits, their higher upfront cost compared to conventional wound closure products can limit adoption, particularly in cost-sensitive healthcare settings. Budget constraints in developing regions and reimbursement limitations may further affect purchasing decisions, creating barriers to widespread utilization of premium absorbable suture products.

Stringent regulatory framework

The stringent regulatory framework governing medical devices and surgical products poses a significant challenge for the absorbable surgical sutures market. Manufacturers must comply with rigorous quality, safety, biocompatibility, and performance standards before obtaining regulatory approvals. Extensive clinical evaluations, documentation requirements, and post-market surveillance obligations can increase product development costs and extend commercialization timelines. These regulatory complexities may delay the introduction of innovative absorbable suture technologies and create barriers for new market entrants, particularly in highly regulated healthcare markets.

Absorbable Surgical Sutures Market Trends

The rising volume of surgical procedures worldwide remains a key factor driving growth in the absorbable surgical sutures market. As healthcare systems expand access to surgical care and medical interventions become more advanced, the demand for effective wound closure solutions, including absorbable and dissolvable sutures, continues to increase. These sutures are widely utilized across a broad range of procedures due to their ability to support tissue healing while eliminating the need for suture removal.
 

According to industry estimates, the U.S. performs more than 4.2 million elective procedures each month, including both surgical and non-surgical interventions. Of these, nearly 46.6% are surgical procedures requiring operating room utilization. Furthermore, data from the International Society of Aesthetic Plastic Surgery (ISAPS) indicates that the U.S. accounted for more than 7.4 million plastic surgery procedures in 2022, representing the highest procedural volume globally.
 

The growing number of elective surgeries, coupled with increasing emergency interventions related to trauma, accidents, and acute medical conditions, is generating sustained demand for advanced absorbable surgical sutures. These products play a critical role in surgical wound closure and post-operative recovery by promoting optimal tissue approximation, minimizing complications, and supporting efficient healing outcomes. As surgical volumes continue to rise across both developed and emerging healthcare markets, the adoption of absorbable surgical sutures is expected to strengthen, reinforcing their importance within the broader surgical sutures market.
 

Absorbable Surgical Sutures Market Analysis

Based on the material, the market is segmented into natural suture and synthetic suture. The synthetic suture segment accounted for 71.4% of the market in 2025 due to their high tensile strength, predictable absorption rates, and minimal tissue reaction, which makes them ideal for complex surgeries and minimally invasive interventions. The segment is expected to exceed USD 3.7 billion by 2034, growing at a CAGR of 5.7% during the forecast period. On the other hand, the natural suture segment is expected to grow with a CAGR of 5.6% from 2026 to 2034. The growth of this segment can be attributed to the rising demand for biologically derived, eco-friendly materials that offer excellent biocompatibility. These sutures are often used in procedures where gentle tissue handling, and rapid absorption are critical.
 

• Synthetic absorbable sutures are manufactured by using materials such as polyglycolic acid (PGA), polylactic acid (PLA), and polydioxanone (PDO), which degrade in a controlled and predictable manner. This allows surgeons to select sutures based on the specific required wound support duration, which ensures that the suture maintains strength during the critical healing phase and is absorbed once it's completed.
   
• In addition, these sutures provide reliable support during the healing process, making them suitable for both surface-level and deeper tissue closures. For example, Medtronic’s Maxon suture is well-known for its durability and is often used in procedures that require extended support.
   
• Additionally, synthetic sutures are designed to be safe and compatible with the body, reducing irritation and the risk of complications after surgery. For instance, B. Braun’s Safil suture, made from polyglycolic acid, is popular for its easy handling and low tissue reactivity, making it ideal for delicate surgeries. These qualities make synthetic sutures a top choice for healthcare professionals, driving growth in the market.
   

Based on the structure, the absorbable surgical sutures market is segmented into monofilament and multifilament. The multifilament segment accounted for the highest market share of 54.1% in 2025.
 

• Multifilament sutures are made of multiple braided or twisted strands, which provide excellent grip and friction. This structure allows for secure knot tying, minimizing the risk of knot slippage during and after surgery. This is especially beneficial in procedures requiring high precision and stability.
   
• For instance, Lotus Surgical’s Solus 910, a braided synthetic absorbable suture which is made from polyglactin 910, and is designed for high knot security, minimal tissue trauma, and consistent absorption, making it ideal for general and specialized surgeries.
   
• Additionally, multifilament sutures are also softer and more flexible, making them easier for surgeons to handle. This improves accuracy and reduces fatigue during longer procedures.
   
• Further, these types of sutures are used in a wide range of procedures, including gynaecological, gastrointestinal, and plastic surgeries, due to their adaptability and reliable performance. Thus, these benefits continue to drive the growth of the multifilament segment in the market.
   

Based on the application, the absorbable surgical sutures market is segmented into cardiovascular surgery, gynaecology surgery, orthopaedic surgery, ophthalmic surgery, neurological surgery, and other surgical applications. The cardiovascular surgery segment accounted for the highest market share of 24.8% in 2025.
 

• The extensive use of absorbable surgical sutures, particularly in cardiovascular surgery, are significantly boosting market growth.
   
• For instance, according to research published in the Thoracic Surgery Reports, over 1 million cardiac surgical procedures are performed globally each year. In high-income countries, the average cardiac surgical volume stands at 123.2 procedures per 100,000 population annually, from 27.3 in South Korea to 271.5 in the U.S. Among these, coronary artery bypass grafting (CABG) accounts for 36.7 procedures, valve surgeries for 30.8, and congenital heart surgeries for 7.9 per 100,000 population.
   
• Further, absorbable sutures play a vital role in cardiovascular applications due to their high tensile strength, minimal tissue reactivity, and predictable absorption profile, which are important in dynamic environments such as the heart and blood vessels.
   

Moreover, innovations in suture technology, such as antibacterial coatings and barbed designs, are improving surgical precision and reducing infection risks. With cardiovascular diseases remaining a leading cause of death worldwide, the demand for advanced absorbable sutures in heart surgeries is expected to grow steadily, further driving the market growth.

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the absorbable surgical sutures market is segmented into hospitals, specialty clinics, ambulatory surgical centres, and other end users. The hospitals segment accounted for the highest market share of 55.3% in 2025.
 

• The increasing number of hospitals both in the developing and developed countries, stimulated by the growing population, increasing prevalence of chronic diseases, and advancement in the surgical sutures, all together propelling the demand for advanced absorbable surgical sutures in the newly established hospital and also in the existing hospital setting.
   
• Further, the rising number of surgical procedures, driven by aging populations, trauma cases, and chronic disease management, is fueling demand for absorbable surgical sutures in hospitals. As hospitals are the primary centres for performing a wide range of surgeries, so does the need for reliable and efficient suturing solutions continues to grow. 
   
• Additionally, the specialty clinics segment, accounting for 21% market share in 2024, is expanding quickly with the growth of dedicated focused care units and outpatient surgical centres. These clinics often perform minimally invasive and elective procedures, favoring absorbable sutures for their ease of use, reduced need for follow-up, and enhanced patient comfort.
   

North America dominated the global absorbable surgical sutures market with the highest market share of 40.4% in 2025. The region has advanced healthcare infrastructure, and the rate of adoption of innovative medical technologies is also high. Further, there is an increasing prevalence of chronic diseases in the U.S. and Canada, thus propelling the growth of this market.
 

• In 2024 the market size reached USD 1.1 billion from USD 1.07 billion in 2023.
   
• The growing prevalence of chronic conditions in the country is driving the need for advanced surgical interventions and effective wound care solutions. As more patients undergo procedures for diseases such as cardiovascular disorders and cancer, the demand for absorbable surgical sutures which support faster healing, reduce infection risks, and eliminate the need for suture removal is rising steadily.
   
• The U.S. is home to 6,093 hospitals as reported by the American Hospital Association, many of which are equipped with state of art operating rooms, fostering the use of conventional and advance suturing technologies.
   
• Additionally, the healthcare expenditure per capita in the U.S. surpassed USD 12,000 in 2023, which translates to significant spending on surgical tools and wound closure materials, further fueling the market expansion.
   

Europe absorbable surgical sutures market accounted for USD 701.7 million in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• Rising prevalence of chronic diseases in the region, coupled with the increasing government initiatives to enhance healthcare infrastructure, is anticipated to spur the growth of the market.
   
• Moreover, the presence of key market players in the region reinforces Europe’s strength in the market. These companies are actively participating in innovation through the development of innovative solutions, thereby aiding market growth.
   

Germany absorbable surgical sutures market is projected to experience steady growth between 2025 and 2034.
 

• The country ranks among the highest in Europe for surgical procedures. Hip and knee replacement are among the most common surgeries which require high strength, durable sutures for wound closure. In 2022, Germany recorded 326.2 hip replacement procedures per 100,000 inhabitants. This indicates an aging orthopaedic patient population, that directly contributes to suture consumption.
   
• Further, the demand for advanced absorbable suture material is rising as healthcare providers increasingly aim to reduce post-operative complications such as surgical site infections (SSI) and support faster recovery.
   
• Additionally, the country’s well-established healthcare practices and research institutions, along with their emphasis on high-quality medical supplies, contribute to the widespread adoption of surgical sutures.
   

The Asia Pacific region is projected to be valued at USD 783 million in 2025 and is expected to reach USD 1.3 billion by 2034.
 

• The absorbable surgical sutures market in the Asia Pacific region is expanding rapidly due to the growing burden of chronic diseases and continuous advancements in sutures materials.
   
• Countries such as China, India and Japan are adopting advanced surgical technologies driven by growing demand for efficient wound closure solutions and expanding access to healthcare services.
   
• Additionally, rapid growth in the number of hospitals and specialty clinics along with government policies aimed at improving surgical capabilities is further contributing to the growth of the market in the region.
   

China absorbable surgical sutures market is poised to witness lucrative growth between 2025 – 2034.
 

• China’s aging population drive orthopaedic and cardiovascular suturing needs. For instance, as per the estimates from World Health Organization (WHO) in 2019, approximately 254 million people of age group 65 and above were residing in the country. This number is projected to rise significantly, with 402 million people expected to be over the age of 60 by 2040.
   
• Furthermore, the growing elderly population is at increased risk of chronic conditions such as cancer, diabetes, and cardiovascular diseases, leading to a higher volume of surgical interventions. This trend is driving the need for advanced wound care solutions, particularly absorbable surgical sutures, which support faster healing, reduce infection risks, and minimize the need for follow-up procedures.
   

Brazil is experiencing significant growth in the absorbable surgical sutures market, driven by its expanding adoption of chronic disease management.
 

• The rising prevalence of chronic diseases such as cardiovascular diseases, neurological disorders, and others are contributing to the growth of the market in the country.
   
• For instance, according to the Brazilian National Health Survey in 2019, there were approximately 12.95 million individuals diagnosed with cardiovascular disease (CVD) in Brazil, with 51% of the affected population being male.
   
• Additionally, the presence of dual healthcare system, Sistema Único de Saúde (SUS), that offers free access to surgical care, thus there is an increase in surgical volume in Brazil, further propelling the market growth.
   

The absorbable surgical sutures market in Saudi Arabia is expected to experience significant and promising growth from 2025 to 2034.
 

• The government of Saudi Arabia is significantly investing in the healthcare infrastructure, to incorporate advanced medical supplies such absorbable surgical sutures within the hospitals setting to provide utmost care to the individuals suffering from the chronic condition in the country.
   
• According to the Saudi Ministry of Health, in 2023, the government had allocated around USD 50.4 billion budget for healthcare infrastructure and social development.
   
• Such investment is anticipated to enhance the accessibility and quality of medical services, among the individuals of the country, accelerating the market growth in the country.
   

Absorbable Surgical Sutures Market Share

• The top five companies B. Braun, Medtronic, Lotus Surgicals, Integra Lifesciences, and Johnson & Johnson together account for 35.8% of the market share in the global market, which remains highly fragmented. These companies stay ahead by offering strong product portfolios, forming strategic partnerships, securing regulatory approvals, and consistently driving innovation.
   
• Johnson & Johnson continues to lead in the absorbable sutures segment. The company focuses on advanced wound closure solutions and provides a variety of synthetic absorbable sutures, including Vicryl, Monocryl, and PDS II. It is also investing in biocompatible materials, antibacterial coatings, and precision engineered needles to deliver better surgical outcomes and lower the risk of infections.
   
• Manufacturers are adopting competitive pricing strategies to expand into price sensitive markets, particularly in emerging economies. Leading players are addressing clinical needs by launching advanced absorbable sutures with predictable degradation profiles, enhanced tensile strength, and antimicrobial properties to reduce post-operative complications and improve patient recovery.
   
• Emerging trends in the absorbable surgical sutures market include the development of sterile, infection-resistant sutures and the adoption of biodegradable polymers specifically engineered for minimally invasive and robotic-assisted surgeries. These advancements are being driven by the increasing demand for precision surgical techniques, accelerated patient recovery, and the shift toward decentralized healthcare delivery models.
   

Absorbable Surgical Sutures Market Companies

Few of the prominent players operating in the absorbable surgical sutures industry include:

• Advanced Medical Solutions
• B. Braun
• Corza Medical
• CONMED
• Demetech
• Futura Surgicare
• Genesis MedTech
• Healthium Medtech
• Integra Lifesciences
• Johnson & Johnson
• Medtronic
• Lotus Surgicals
• Unisur
• Vital Sutures
• Vitrex Medical Group
   
• Johnson & Johnson

Johnson & Johnson’s absorbable sutures market lies in its precision-engineered suture and needle technologies under the Ethicon brand. The company offers a wide range of absorbable sutures, including antibacterial-coated options and knotless tissue control devices, designed to reduce infection risk and improve surgical efficiency.
 

• Lotus Surgicals

Lotus Surgicals differentiates itself through its commitment to precision manufacturing and a comprehensive portfolio of absorbable sutures tailored for high-acuity procedures. It offers a full range of braided and monofilament absorbable sutures, including advanced products such as Solus (PGA), Solus 910 (Polyglactin 910), and SOLUS 910 AM+ with antibacterial triclosan coating, designed for specialties such as cardiovascular, transplant, and plastic surgeries.
 

• Medtronic

Medtronic holds a significant share in the surgical suture market through its comprehensive surgical solutions' portfolio. Medtronic emphasizes R&D and product development offerings specialty sutures with enhances tensile strength and handling properties.
 

Absorbable Surgical Sutures Industry News

• In January 2026, Smith+Nephew completed the acquisition of Integrity Orthopaedics, a specialist in shoulder repair technologies. The transaction strengthened Smith+Nephew’s sports medicine portfolio by adding the Tendon Seam™ repair system and advanced suture-based fixation technologies, further expanding its presence in the orthopedic surgery market.
   
• In June 2026, McKesson Corporation completed a strategic investment transaction with Apollo Funds, which acquired an approximately 13% stake in McKesson’s Medical-Surgical Solutions business for $1.25 billion. The deal valued the division at approximately $13 billion and is expected to support the expansion of its medical and surgical product distribution capabilities.
   

The absorbable surgical sutures market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Material

• Natural suture
• Synthetic suture
  • Vicryl
  • Polydioxanone suture (PDS)
  • Poliglecaprone suture (Monocryl)

Market, By Structure

• Monofilament
• Multifilament

Market, By Application

• Gynaecology surgery
• Orthopaedic surgery
• Ophthalmic surgery
• Neurological surgery
• Other surgical applications

Market, By End Use

• Hospitals
• Specialty clinics
• Ambulatory surgical centres
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE